BioSpace News Archive

CEL-SCI Corporation (NYSE American: CVM) announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) has completed its recent review of the Phase 3 study data.

Genprex, Inc. is a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform

Dr. Johnson brings more than 25 years of experience guiding the regulatory and product development strategies for biotechnology and pharmaceutical companies in all stages of development and across a range of therapeutic areas.

Nearly 5,000 diabetes educators may be inclined to say “yes"--gut bacteria are at the root of the disease after they visit the Prebiotin booth at this year’s American Association of Diabetes Educators (AADE) Annual Conference (held in Baltimore, MD, August 17-20).

The top accounting, human resources, and answering services companies presented today have proven their ability to deliver quality work to clients, according to research announced by ratings and reviews company Clutch.

Maxim will focus on assisting BioStem Technologies with its strategies for maximizing shareholder value through its full scope of investment banking services.

AXIM® Biotechnologies, Inc. announced that the Company will be attending and presenting at BIT’s 16th Annual Congress of International Drug Discovery Science and Technology-2018 (IDDST-2018)

Radiologist bringing ‘start-up’ mentality to inspire medical innovation in Canada

Cancer Treatment Centers of America® (CTCA) Chicago is proud to announce Marie Allen as the new president of the CTCA® Chicago Board of Directors.